Journal of Comparative Effectiveness Research provides a rapid-publication platform for debate, and for the presentation of new findings and research methodologies.Through rigorous evaluation and comprehensive coverage, the Journal of Comparative Effectiveness Research provides stakeholders (including patients, clinicians, healthcare purchasers, and health policy makers) with the key data and opinions to make informed and specific decisions on clinical practice.
《比较有效性研究杂志》提供了一个快速发表的平台，用于讨论、展示新的发现和研究方法。通过严格的评估和全面的报道，《比较有效性研究杂志》为利益相关者（包括患者、临床医生、医疗保健购买者和卫生政策制定者）提供了关键数据和意见，以便在临床实践中做出明智和具体的决策。
Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low- and middle-income countries.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0102
Persistence and adherence of biologics in US patients with psoriatic arthritis: analyses from a claims database.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0023
Variation in prostate surgery costs and outcomes in the USA: robot-assisted versus open radical prostatectomy.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0109
Ospemifene versus local estrogen: adherence and costs in postmenopausal dyspareunia.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0091
Indicator of access to medicines in relation to the multiple dimensions of access.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0031
Patients’ early engagement in research proposal development (PEER-PD): patients guiding the proposal writing
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0129
Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0108
Minimally-invasive surgery for degenerative spondylolisthesis: transforaminal or oblique lumbar interbody fusion.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0055
Cost-effectiveness of elagolix versus leuprolide acetate for treating moderate-to-severe endometriosis pain in the USA.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0124
A cost-utility analysis of dulaglutide versus insulin glargine as third-line therapy for Type 2 diabetes in Canada.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0073
Multi-gene assays: effect on chemotherapy use, toxicity and cost in estrogen receptor-positive early stage breast cancer.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0137
Sickle cell disease and readmissions rates after lower extremity arthroplasty: a multistate analysis 2007-2014.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0098
Patient characteristics and stroke and bleeding events in nonvalvular atrial fibrillation patients treated with apixaban and vitamin K antagonists: a Spanish real-world study.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0079
Clinical and economic outcomes of ProGlide compared with surgical repair of large bore arterial access.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0082
Sexually transmitted infections in privately insured adults with intellectual and developmental disabilities.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0011
Reporting and analyses of sex/gender and race/ethnicity in randomized controlled trials of interventions published in the highest-ranking anesthesiology journals.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0071
Comparative outcome of induced labor by intracervical Foley catheter with misoprostol versus misoprostol alone.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0077
Comparative effectiveness of a human fibroblast-derived dermal substitute and a viable cryopreserved placental membrane for the treatment of diabetic foot ulcers.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0001
Osimertinib in first-line treatment of advanced EGFR-mutated non-small-cell lung cancer: a cost-effectiveness analysis.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0029
Cost minimization analysis of catheter ablation for paroxysmal atrial fibrillation by catheter technology.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0110
Mental state, psychoemotional status, quality of life and treatment compliance in patients with Type 2 diabetes mellitus.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0105
Comparative clinical effects and cost-effectiveness of maximum androgen blockade, docetaxel with androgen deprivation therapy and ADT alone for the treatment of mHSPC in China.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0133
Comparison between oral and intravenous application of tranexamic acid for total hip arthroplasty: a meta-analysis.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0120
Efficiency of acute public hospitals in the region of Murcia, Spain.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0150
Ability to pay for medication: a clustering analysis of 1404 patients with the Patient Financial Eligibility Tool.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0063
Comparative and combined effectiveness of innovative therapies in cancer: a literature review.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0131
Complications in type III open tibial shaft fractures treated with open reduction and internal fixation.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0040
Ceftriaxone versus ampicillin/sulbactam for the treatment of aspiration-associated pneumonia in adults.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0041
Is routine baseline brain imaging needed for all newly diagnosed non-small-cell lung cancer patients?
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0148
Incremental direct healthcare expenditures of valvular heart disease in the USA.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0007
Does evidence matter? Comparative effectiveness research and prescribing of Type 2 diabetes mellitus drugs.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0127
How different is research done by the Patient-centered Outcomes Research Institute, and what difference does it make?
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0054
Intravenous tranexamic acid reduces blood transfusions in revision total hip arthroplasty: a meta-analysis.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0030
Policy perspectives on alternative models for pharmaceutical rebates: a report from the Institute for Clinical and Economic Review Policy Summit.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0094
Positive deviance approaches to improving vaccination coverage rates within healthcare systems: a systematic review.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0056
Systematic review of societal costs associated with stroke, bleeding and monitoring in atrial fibrillation.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0089
Using flowable gelatin in anterior cervical spine surgery in real-world practice: a retrospective cohort study.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0121
Factors associated with evidence-based decision-making among patients and providers.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0152
Engaging parent-child dyad and healthcare provider stakeholders in a patient-centered comparative effectiveness study.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0126
Complications and associated healthcare costs of transvenous cardiac pacemakers in Germany.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0114
Factors related to the comparative effectiveness of clozapine in patients with schizophrenia.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0096
Cost-effectiveness of tacrolimus for the treatment of moderate-to-severe lupus nephritis in China.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0111
Putting patients first: an inventive service delivering cancer treatment at home.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0038
Costs, exacerbations and pneumonia after initiating combination tiotropium olodaterol versus triple therapy for chronic obstructive pulmonary disease.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0101
Twelve-month healthcare utilization and expenditures in Medicare fee-for-service patients with clinically significant mitral regurgitation.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0026
Improving the quality of economic evaluation in health in low- and middle-income countries: where are we now?
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0119
Cost minimization comparison of oral UFT/leucovorin versus 5-fluorouracil/leucovorin as adjuvant therapy for colorectal cancer in Taiwan.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0078
Gelatin tannate versus other antidiarrheal medication in children with acute gastroenteritis: a retrospective, observational study.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2018-0082
Treatment patterns and costs among biologic-naive patients initiating apremilast or biologics for psoriatic arthritis.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0034
Facilitators and barriers to successful recruitment into a large comparative effectiveness trial: a qualitative study.
来源期刊：Journal of comparative effectiveness researchDOI：10.2217/cer-2019-0010
